| Mrs Tori Paige Chastain, SLP | |
|
324 Aquone Rd, Andrews, NC 28901-7003 | |
| (828) 557-1284 | |
| (828) 237-4591 |
| Full Name | Mrs Tori Paige Chastain |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 324 Aquone Rd, Andrews, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831758721 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 20030311 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tori Paige Chastain, SLP Po Box 780, Hayesville, NC 28904-0780 Ph: () - | Mrs Tori Paige Chastain, SLP 324 Aquone Rd, Andrews, NC 28901-7003 Ph: (828) 557-1284 |
News Archive
In the age of tablet computers and smart phones, it's easy to feel inundated and overloaded by information. But on a cellular level, this bombardment is business as usual, and a team of University of Washington researchers has identified a mechanism that some plant cells use to receive complex and contradictory messages from their neighbors.
Applying mathematical models used for studying the galaxies or interactions between elementary particles, researchers at the Institute of Neuroscience of the Universitat Autònoma de Barcelona, in collaboration with Massachusetts General Hospital, Boston, have analysed the spatial distribution of astrocytes: brain cells that are essential for the correct functioning of neurons.
Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Bupropion HCl Extended-Release tablets 100mg and 200mg. Distribution of the product will commence immediately.
FLUIDDA's breakthrough imaging technology was used to assess the mode of action of Roflumilast, a novel drug to treat patients suffering from chronic obstructive pulmonary disease (COPD).
Given that epilepsy impacts more than 2 million Americans, there is a pressing need for new therapies to prevent this disabling neurological disorder. New findings from the neuroscience laboratory of Mark S. Shapiro, Ph.D., at The University of Texas Health Science Center at San Antonio, published Dec. 20 in the high-impact scientific journal, Neuron, may provide hope.
› Verified 1 days ago
Elizabeth Grace Gunter, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 324 Aquone Rd, Andrews, NC 28901 Phone: 828-557-1284 | |
Kimberly June Flaherty, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 551 Kent St, Andrews, NC 28901 Phone: 828-321-3075 | |
Ms. Valerie Marie Mashburn, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2135 Us 19 Bus, 2135 Us 19 Bus, Andrews, NC 28901 Phone: 828-321-0511 Fax: 828-321-0511 | |
Mrs. Heather Nicole Gibson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 551 Kent St, Andrews, NC 28901 Phone: 828-321-3075 | |
Lindsay Marie Drake, M.S. SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 324 Aquone Rd, Andrews, NC 28901 Phone: 828-557-1284 | |
Kelly Patterson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 551 Kent St, Andrews, NC 28901 Phone: 828-321-3075 |